Pennsylvania’s cannabis industry stands at a historic crossroads. With Senate Bill 120 advancing further than any recreational legalization bill in state history and the medical market generating record quarterly sales, NECANN Philadelphia 2026 arrives at the perfect moment for cultivators, processors, and compliance teams to position themselves for what comes next.
This is NECANN’s first Philadelphia event. After the successful 2025 Pittsburgh convention attracted 60+ exhibitors, NECANN partnered with the Pennsylvania Cannabis Convention (PACC) to bring an expanded two-day format to the state’s largest city at the Pennsylvania Convention Center.
Pennsylvania ranks as the 6th largest cannabis retail market in the U.S. despite being medical-only, with over 446,000 active patients and Q1 2025 setting a quarterly sales record.
Whether you’re preparing for vertical integration under Act 63, navigating MJ Freeway integration challenges, or evaluating the potential adult-use transition under SB 120, NECANN Philadelphia brings together the decision-makers shaping Pennsylvania’s cannabis future.
NECANN Philadelphia draws professionals across the cannabis supply chain, with particular value for those navigating Pennsylvania’s evolving regulatory landscape and preparing for potential adult-use market entry.
Pennsylvania’s regulatory landscape shifted dramatically in 2025. Senate Bill 120 cleared the Senate Law and Justice Committee in October 2025, marking the furthest any recreational marijuana bill has advanced in Pennsylvania’s legislative history. Meanwhile, Act 63 vertical integration rules took full effect in April 2024, reshaping competitive dynamics.
Operators attending NECANN Philadelphia face consequential choices: whether to pursue vertical integration before potential adult-use licensing, how to prepare compliance infrastructure for a possible Cannabis Control Board transition, and when to invest in scaling cultivation capacity for a market that could open recreational sales by late 2026 or early 2027.
The state crossed $7.68 billion in cumulative retail sales, ranking Pennsylvania as the 6th largest cannabis market nationally despite being medical-only.
Pennsylvania State Cannabis / PA DOH Data, 2025Whether you’re attending for the first time or building on connections from the 2025 Pittsburgh event, these practical tips will help you maximize your conference experience.
Understanding Pennsylvania’s regulatory environment is essential for any operator considering market entry or expansion. The Department of Health’s Office of Medical Marijuana oversees one of the most developed medical programs in the nation, with 24 qualifying conditions serving 446,000+ active patients.
Related: Seed to Sale SoftwarePennsylvania stands at a historic inflection point. Senate Bill 120 has advanced further than any recreational cannabis bill in the state’s history, while the medical market has generated $7.68 billion in cumulative sales serving over 446,000 patients. Understanding the regulatory trajectory is critical for operators attending NECANN Philadelphia 2026.
Pennsylvania ranks as the 6th largest cannabis retail market in the United States despite being medical-only. The state’s Q1 2025 sales set a quarterly record, and the projected late 2026/early 2027 adult-use market opening would create significant expansion opportunities for current operators and new entrants alike.
The convergence of SB 120’s legislative progress, the potential track-and-trace system transition, and vertical integration consolidation creates a unique window for strategic positioning. Attendees should prepare to discuss compliance system migration strategies, adult-use license application preparation, and partnership opportunities with Pennsylvania’s 32 grower/processors and 188 dispensaries.
Note: Cannabis regulations evolve rapidly. This information is for educational purposes only and should be verified with current PA DOH guidance.
Cannabis businesses operating in Pennsylvania encounter operational complexities that require significant planning and system adaptation. Conference attendees frequently discuss these common challenges:
No two-way API integration forces manual data entry between tracking, lab testing, and point-of-sale systems, creating compliance risks and operational inefficiencies
All packaging and label content requires DOH written approval before use, with strict requirements on cannabinoid percentages, warning statements, and prohibited content
24/7 professionally-monitored surveillance with 48-hour auxiliary power backup requirements and strict malfunction notification protocols
Preparing for potential system migration following PA’s November 2023 RFP for replacement provider while maintaining current MJ Freeway compliance
Maximize your conference ROI by arriving prepared. Use this checklist to ensure you’re ready to make the most of every networking opportunity and vendor discussion.
Common questions from cannabis professionals planning to attend NECANN Philadelphia 2026.
NECANN Philadelphia welcomes both industry professionals and the public. Medical marijuana patients receive free expo admission with registration. The event combines B2B networking with consumer education.
Yes, all attendees must be 21 years of age or older. Valid ID is required at registration.
General Admission costs $20 for expo access only. Registered Pennsylvania medical marijuana patients attend free. A Two-Day Pass at $100 includes expo access, programming sessions, networking events, and the Friday Industry Social pre-party.
No. Pennsylvania Convention Center rules prohibit cannabis sales or consumption on venue grounds. The Friday Industry Social at an off-site location may have different policies; check event updates closer to April.
Pennsylvania does not recognize out-of-state medical marijuana cards. However, all adults 21+ can attend the convention regardless of patient status.
Online registration remains open until the event. Cash ticket purchases are available at the venue. For exhibitors, booth availability is first-come, first-served via the MAP Dynamics platform.
Operating in Pennsylvania requires seed-to-sale software that handles MJ Freeway integration challenges while supporting the complexities of indoor cultivation mandates, DOH packaging approval workflows, and stringent security documentation requirements. These systems help operators maintain audit-ready records across cultivation, processing, and distribution activities.
GrowerIQ provides state tracking system integration for Pennsylvania cannabis compliance, multi-facility management supporting vertical integration workflows, batch tracking from seed through sale, and compliance automation reducing manual reporting burden during potential track-and-trace system transitions.
See how cannabis facilities in Pennsylvania use GrowerIQ to manage seed-to-sale traceability, state tracking integration, and regulatory reporting.
Request Demo